(4)Reaction mass of 2,2'-[(1-methylpropane-1,3-diyl)bis(oxy)]bis[4-methyl-1,3,2-dioxaborinane] and 2,2'-oxybis(4,4,6-trimethyl-1,3,2-dioxaborinane) has not been evaluated for use in biocidal products of product-type 6. As that substance is not listed among the substance/product-type combinations included in the review programme on 17 March 2022, as set out in Annex II to Commission Delegated Regulation (EU) No 1062/2014note, it is not included in the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012. Article 89 of Regulation (EU) No 528/2012 allowing Member States to continue to apply their current system or practice of making available on the market or using a given biocidal product therefore does not apply to that active substance. Therefore, this active substance needs to be assessed and approved before biocidal products containing it can be authorised also at national level.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.